Development of Betalactam‐Predictor: A Clinical Decision Tool for Delabeling Low‐Risk Betalactam Allergy Patients. Initial Validation in Penicillin Allergy
This score would simplify diagnostic procedures in low-risk patients, enabling rapid delabeling, potentially in non-specialty settings, and reducing diagnostic costs and the negative consequences associated with incorrect antibiotic allergy labels.
Authors
- Holger Mosbech
- I. Dona
- Mariana Castells (ORCID: https://orcid.org/0000-0001-6451-0163)
- E. Silva Moreno
- Giovanna Sfriso
- Elizabeth Phillips
- Annick Barbaud
- María José Torres
- Jose Julio Laguna
- Jonas Bredtoft Boel
- Patrizia Bonnadona
- Lene Heise Garvey
- Julia Rodríguez de Guzmán
- Rafael Nuñez
Institutions
- University of Copenhagen (DK)
- Brigham and Women's Hospital (US)
- Harvard University (US)
- Inserm (FR)
- Universidad de Salamanca (ES)
- Gentofte Hospital (DK)
- Sorbonne Université (FR)
- Azienda Ospedaliera Universitaria Integrata Verona (IT)
- Hospital Regional Universitario de Málaga (ES)
- Institut Pierre Louis d‘Épidémiologie et de Santé Publique (FR)
- Instituto de Investigación Biomédica de Salamanca (ES)
- Universidad Alfonso X el Sabio (ES)
- Andalusian Centre for Nanomedicine and Biotechnology (ES)
- Ospedale San Bortolo (IT)
- Instituto de Investigación Biomédica de Málaga (ES)
- Universidad de Málaga (ES)
- Vanderbilt University Medical Center (US)
Publication Details
- Journal
- Allergy
- Published
- 2026-01-19
- DOI
- https://doi.org/10.1111/all.70222
- Primary Topic
- Drug-Induced Adverse Reactions
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- European Academy of Allergy and Clinical Immunology